Reuters -- OSI Pharmaceuticals Inc, which has been fending off a hostile takeover bid by Japan’s Astellas Pharma Inc, reported much lower first quarter profit on Thursday as results were hit by costs associated with the tender offer.
Reuters -- OSI Pharmaceuticals Inc, which has been fending off a hostile takeover bid by Japan’s Astellas Pharma Inc, reported much lower first quarter profit on Thursday as results were hit by costs associated with the tender offer.
